Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence pattern, which limits subsequent therapeutic options. Th...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Huveldt, Deborah, Lewis-Tuffin, Laura J., Carlson, Brett L., Schroeder, Mark A., Rodriguez, Fausto, Giannini, Caterina, Galanis, Evanthia, Sarkaria, Jann N., Anastasiadis, Panos Z.
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2013
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3572988/
https://ncbi.nlm.nih.gov/pubmed/23457577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056505
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы